nep-ias New Economics Papers
on Insurance Economics
Issue of 2021‒10‒25
five papers chosen by
Soumitra K. Mallick
Indian Institute of Social Welfare and Business Management

  1. Occasional Bulletin of Economic Notes 202101 Why the pandemic is lowering medical insurance inflation By Kathryn Bankart; Elise Green; Dineo Lekgeu; Koketso Mano; Mpho Rapapali
  2. Uncertain Monsoon, Irrigation and Crop Yields: Implications for Pricing of Insurance Products By Amale, Hardeep S.; Negi, Digvijay S.
  3. Success factors of very small businesses in regulated context: Case of Moroccan insurance brokers By Lahoucine Outolba; Abdelhaq Lahfidi
  4. Insurance Companies and the Growth of Corporate Loan Securitization By Fulvia Fringuellotti; João A. C. Santos
  5. The effects of India’s COVID-19 lockdown on critical non-COVID health care and outcomes: evidence from a retrospective cohort analysis of dialysis patients By Jain, Radhika; Dupas, Pascaline

  1. By: Kathryn Bankart; Elise Green; Dineo Lekgeu; Koketso Mano; Mpho Rapapali
    Abstract: Occasional Bulletin of Economic Notes 2021/01 Why the pandemic is lowering medical insurance inflation
    Date: 2021–10–06
  2. By: Amale, Hardeep S.; Negi, Digvijay S.
    Keywords: Risk and Uncertainty, Agricultural and Food Policy, International Development
    Date: 2021–08
  3. By: Lahoucine Outolba (UIZ - Ibn Zohr University of Agadir); Abdelhaq Lahfidi (UIZ - Ibn Zohr University of Agadir)
    Keywords: Small businesses,Regulation,Entrepreneurship success. Classification JEL: M10 Paper type: Empirical research
    Date: 2021–10–01
  4. By: Fulvia Fringuellotti; João A. C. Santos
    Abstract: Collateralized loan obligation (CLO) issuances in the United States increased by a factor of thirteen between 2009 and 2019, with the volume of outstanding CLOs more than doubling to approach $647 billion by the end of that period. While researchers and policy makers have been investigating the impact of this growth on the cost and riskiness of corporate loans and the potential implications for financial stability, less attention has been paid to the drivers of this phenomenon. In this post, which is based on our recent paper, we shed light on the role that insurance companies have played in the growth of corporate loans’ securitization and identify the key factors behind that role.
    Keywords: insurance companies; CLOs; regulatory arbitrage; corporate loans; securitization
    JEL: G2
    Date: 2021–10–13
  5. By: Jain, Radhika; Dupas, Pascaline
    Abstract: India’s COVID-19 lockdown, one of the most severe in the world, is widely believed to have disrupted critical non-COVID health services. However, linking these disruptions to effects on health outcomes has been difficult due to the lack of reliable, up-to-date health outcomes data. We identified all dialysis patients under a statewide health insurance program in Rajasthan, India, and conducted surveys to examine the effects of the lockdown on care access, morbidity, and mortality. 63% of patients experienced a disruption to their care. Transport barriers, hospital service disruptions, and difficulty obtaining medicines were the most common causes. We compared monthly mortality in the four months after the lockdown with pre-lockdown mortality trends, as well as with mortality trends for a similar cohort in the previous year. Mortality in May 2020, after a month of exposure to the lockdown, was 1.70 percentage points or 64% (p=0.01) higher than in March 2020 and total excess mortality between April and July was estimated to be 22%. Morbidity, hospitalization, and mortality between May and July were strongly positively associated with lockdown-related disruptions to care, providing further evidence that the uptick in mortality was driven by the lockdown. Females, socioeconomically disadvantaged groups, and patients living far from the health system faced worse outcomes. The results highlight the unintended consequences of the lockdown on critical, life-saving non-COVID health services that must be taken into account in the implementation of future policy efforts to control the spread of pandemics.
    Keywords: COVID-19; Pandemic; Non-pharmaceutical intervention; Excess mortality; Non-communicable disease; Dialysis; Chronic kidney disease; Health systems
    JEL: I10 I14 I18
    Date: 2021–06–11

This nep-ias issue is ©2021 by Soumitra K. Mallick. It is provided as is without any express or implied warranty. It may be freely redistributed in whole or in part for any purpose. If distributed in part, please include this notice.
General information on the NEP project can be found at For comments please write to the director of NEP, Marco Novarese at <>. Put “NEP” in the subject, otherwise your mail may be rejected.
NEP’s infrastructure is sponsored by the School of Economics and Finance of Massey University in New Zealand.